AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CHIMERIC THERAPEUTICS LTD

0.011

-0.002-15.38%

Volume:1.87M

Turnover:22.90K

Market Cap:779.19K

PE:-0.01

High:0.014

Open:0.013

Low:0.011

Close:0.013

52wk High:0.400

52wk Low:0.011

Shares:70.84M

Float Shares:29.07M

Volume Ratio:0.46

T/O Rate:6.45%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.758

EPS(LYR):-0.772

ROE:-1290.99%

ROA:-26.96%

PB:-0.26

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Chimeric Therapeutics Ltd - Major Cost Reductions Implemented, Expected to Reduce Annualised Expenditure by Around A$4 Mln

THOMSON REUTERS

Chimeric Therapeutics Ltd - Intends to Enter Negotiations with Its Creditors

THOMSON REUTERS

Chimeric Therapeutics Ltd - FY26 Financial Report Expected to Include a Material Uncertainty in Relation to Going Concern

THOMSON REUTERS

Chimeric Therapeutics - Conducted Process to Explore Potential to Sell, Out Licence or Partner Chm Cdh17 Asset and Programme

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Trading app for stocks, options & ETFs","description":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","keywords":"tiger brokers,tiger brokers au,tiger brokers australia,tiger trade,tiger trading,australia stock platform,US option,US stocks,stocks and options,australian trading platform,online broker australia,stock trading apps,mobile trading app,desktop trading,chess sponsored brokers,share trading platform","social":{"ogDescription":"Invest in US, ASX, HK, China A-shares, ETFs & options with Tiger Brokers, Australia's trusted stock trading app!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au.tigermarketb.com/stock/CHM.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"AUS","license":"TBAU","edition":"fundamental","symbol":"CHM.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CHM.AU\",,,,,undefined,":{"symbol":"CHM.AU","market":"AU","secType":"STK","nameCN":"CHIMERIC THERAPEUTICS LTD","latestPrice":0.011,"timestamp":1787724720000,"preClose":0.013,"halted":0,"volume":1873645,"delay":0,"changeRate":-0.15384615384615385,"nameEN":"CHIMERIC THERAPEUTICS LTD","floatShares":29070766,"shares":70835203,"eps":-0.758007,"marketStatus":"Not Yet Opened","change":-0.002,"latestTime":"08-26 16:12:00 AEST","open":0.013,"high":0.014,"low":0.011,"amount":22899,"amplitude":0.230769,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.758007,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.013,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":0.4642413414368729,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CHM.AU","preClose":0.013,"auctionPrice":0.011,"auctionVolume":293640,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724605218}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CHM.AU\",,,,,undefined,":{"symbol":"CHM.AU","floatShares":29070766,"roa":"-26.96%","roe":"-1290.99%","lyrEps":-0.771524,"volumeRatio":0.4642413414368729,"shares":70835203,"dividePrice":0,"high":0.014,"amplitude":0.230769,"preClose":0.013,"low":0.011,"week52Low":0.011,"pbRate":"-0.26","psRate":"0.08","week52High":0.4,"institutionHeld":0,"latestPrice":0.011,"eps":-0.758007,"divideRate":0,"volume":1873645,"delay":0,"ttmEps":-0.758007,"open":0.013,"prevYearClose":0.2,"prevWeekClose":0.02,"prevMonthClose":0.043,"prevQuarterClose":0.065,"fiveDayClose":0.019,"twentyDayClose":0.043,"sixtyDayClose":0.1,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CHM.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2026-04-22","symbol":"CHM.AU","defaultRemindTime":1776816000000,"type":"split","dateTimestamp":1776780000000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CHM.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CHM.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660490216","title":"Chimeric Therapeutics Ltd - Major Cost Reductions Implemented, Expected to Reduce Annualised Expenditure by Around A$4 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490216","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490216?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:09","pubTimestamp":1787094560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F16D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660490215","title":"Chimeric Therapeutics Ltd - Intends to Enter Negotiations with Its Creditors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660490215","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660490215?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:09","pubTimestamp":1787094560,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F16D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660349021","title":"Chimeric Therapeutics Ltd - FY26 Financial Report Expected to Include a Material Uncertainty in Relation to Going Concern","url":"https://stock-news.laohu8.com/highlight/detail?id=2660349021","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660349021?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:09","pubTimestamp":1787094560,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F16D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","CHM.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660270490","title":"Chimeric Therapeutics - Conducted Process to Explore Potential to Sell, Out Licence or Partner Chm Cdh17 Asset and Programme","url":"https://stock-news.laohu8.com/highlight/detail?id=2660270490","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660270490?lang=en_us&edition=fundamental","pubTime":"2026-08-19 07:09","pubTimestamp":1787094560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F16D:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CHM.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":19,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/CHM.AU\",params:#limit:6,delay:true,,,undefined,":[]}}